Dr. Elie Haddad is a clinician scientist in pediatric immunology, Professor of Pediatrics at the University of Montreal. His clinical research focuses on primary immune deficiency. He is President-Elect of the Clinical Immunology Society and he is one of the three PI of the Primary Immune Deficiency Treatment Consortium, an NIH-funded consortium of 47 North-American Centers. The major activity of his fundamental research is on immunotherapy, mostly in the field of NK-cell and stem-cell-based cellular therapy. Dr. Haddad has also set up a humanized mice platform to develop innovative preclinical models of cancer immunotherapy and the study of immunopathology.